Properties of fibrinogen-antigenic material on the rheumatoid synovial membrane and in the rheumatoid synovial fluid
- PMID: 712203
Properties of fibrinogen-antigenic material on the rheumatoid synovial membrane and in the rheumatoid synovial fluid
Abstract
Fibrin deposits on rheumatoid synovial membranes and fibrinogen-antigenic material in rheumatoid synovial fluid were found to be identical by crossed immunoelectrophoresis into immunoglobulin against fibrinogen, by SDS-polyacrylamide gel electrophoresis, and by gel filtration on Sepharose CL 6B. The material was found to be neither fibrinogen nor fibrin, but degradation products. One of the fragments was purified by preparative agarose electrophoresis, and the physicochemical properties of this fragment were found to be different from those obtained by plasmin digestion of fibrinogen or fibrin. This indicates that other proteases than plasmin are responsible for the degradation products. The material was easily degraded by plasmin to D- and E-antigenic end products, identical to those obtained by plasmin digest of fibrinogen. The solubility of the material was poor in synovial fluid compared to serum and buffer. On the basis of these results, it is suggested that the fibrinlike material on the synovial membrane represents fibrinogen degradation products from the inflamed tissue. These products are likely released into the synovial fluid, and when their concentration here exceeds their solubility, they precipitate on the synovial membrane.
Similar articles
-
Fibrinogen/fibrin degradation products in exudates from bullous dematoses.Acta Derm Venereol. 1979;59(4):293-6. Acta Derm Venereol. 1979. PMID: 92141
-
Fibrin degradation in the synovial fluid of rheumatoid arthritis patients: a model for extravascular fibrinolysis.Semin Thromb Hemost. 1996;22(6):489-96. doi: 10.1055/s-2007-999049. Semin Thromb Hemost. 1996. PMID: 9122713 Review.
-
Effect of the common bile acids on the fibrin/fibrinogen fragments in rheumatoid synovial fluid. A possible clue to the ameliorating effect of jaundice in rheumatoid arthritis.Scand J Rheumatol. 1975;4(3):158-64. doi: 10.3109/03009747509165446. Scand J Rheumatol. 1975. PMID: 52191
-
Association of citrullinated proteins with synovial exosomes.Arthritis Rheum. 2006 Dec;54(12):3809-14. doi: 10.1002/art.22276. Arthritis Rheum. 2006. PMID: 17133577
-
Antirheumatic drug concentrations in human synovial fluid and synovial tissue. Observations on extravascular pharmacokinetics.Clin Pharmacokinet. 1983 Nov-Dec;8(6):496-522. doi: 10.2165/00003088-198308060-00002. Clin Pharmacokinet. 1983. PMID: 6360465 Review.
Cited by
-
Protein synthesis in rheumatoid synovial tissue.Springer Semin Immunopathol. 1981;4(2):103-23. doi: 10.1007/BF01857090. Springer Semin Immunopathol. 1981. PMID: 7323952
-
Neutral protease secretion by human monocytes. Effect of surface-bound immune complexes.J Exp Med. 1979 Apr 1;149(4):954-68. doi: 10.1084/jem.149.4.954. J Exp Med. 1979. PMID: 429965 Free PMC article.
-
Circulating monoclonal IgM lambda cryoglobulin with collagen type I affinity in vasculitis.Clin Exp Immunol. 1986 Jun;64(3):587-96. Clin Exp Immunol. 1986. PMID: 3098468 Free PMC article.
-
Decreased levels of the gelsolin plasma isoform in patients with rheumatoid arthritis.Arthritis Res Ther. 2008;10(5):R117. doi: 10.1186/ar2520. Epub 2008 Sep 27. Arthritis Res Ther. 2008. PMID: 18822171 Free PMC article.
-
Rheumatoid nodules. A lightmicroscopical study with special reference to fibrin and fibronectin.Histochemistry. 1984;80(5):463-7. doi: 10.1007/BF00495435. Histochemistry. 1984. PMID: 6207148